A shorter course of AZT therapy can reduce HIV transmission from mothers to children, now available at a lower cost. The study found that treatment regimens starting at 28 weeks pregnant and given to the infant for six weeks resulted in a transmission rate similar to standard long/long treatment.
At the Institute of Human Virology (IHV) conference, scientists from Africa, Caribbean, and US/Europe discussed HIV/AIDS challenges in the developing world. They emphasized the need for more North-South partnerships to address affordable therapies and preventative vaccines.
Researchers describe a medical paradox where some AIDS patients develop opportunistic infections after regaining immune strength from HAART therapy. The 'immune reconstitution disease syndrome' occurs when the strengthened immune system reacts to bacteria or viruses already present in the patient.
New data from an NHLBI pediatric AIDS study show no significant differences in cardiac function between children exposed to AZT and those not exposed. The study provides reassuring evidence that AZT is not associated with any significant negative clinical effects on the heart.
Leading AIDS researchers, including Robert Gallo and Seth Berkeley, urge a new era of scientific cooperation to accelerate HIV vaccine development. The epidemic affects 40 million people worldwide, and current funding and resources are insufficient.
Researchers from Emory University Health Sciences Center have identified three HIV-positive chimpanzees that are progressing to AIDS, offering insights into how the disease develops and may be resisted. The chimps' unique genetic profile could hold key to developing an HIV vaccine and new treatments for AIDS.
A new mathematical model developed by University of Michigan scientist Denise Kirschner shows how HIV accelerates the normal process of homing, diverting white blood cells from the bloodstream to the lymph system. This understanding is crucial for developing effective treatments and targeting therapeutic drugs.
A new study at the University of North Carolina finds that men infected with HIV who use denial strategies to cope with the disease threat progress more rapidly to AIDS. Higher average blood levels of cortisol are also associated with faster progression.
A recent study found that a short regimen of nevirapine continues to reduce HIV transmission in infants even when breastfed. The results showed a sustained 39% reduction in risk over 12 months, and preliminary data suggest an additional 2% reduction after 18 months.
A recent San Francisco study found that antiretroviral treatment continues to significantly improve AIDS patient survival rates, with a 60% reduction in risk of death for those receiving HAART. The study also revealed increased survival benefits over time, particularly among those diagnosed between 1996 and 1997.
Researchers found that women carry lower levels of HIV in their blood than men, especially during early phases of infection, but have the same risk as men of developing AIDS. Current guidelines may lead to more men being eligible for treatment due to lower viral load thresholds.
A study by the San Francisco Department of Public Health found that anonymous HIV screening of jail inmates offers an opportunity to track the epidemic in at-risk groups. The study detected a higher number of STDs than typically picked up in screening programs outside the jail setting.
The Bay Area Perinatal AIDS Center's coordinated care model significantly reduces HIV transmission from mother to child. Nurse clinicians focus on the challenges of caring for HIV-infected mothers, implementing interventions such as coordinated medication schedules.
Despite new treatments extending lives of individuals with HIV, the overall shortfalls in AIDS treatments are becoming apparent. The US data shows a stabilization in AIDS cases and deaths diagnosed each quarter since July 1998, with roughly 4,000 AIDS deaths and 10,000 AIDS cases diagnosed annually.
Researchers from UNC Chapel Hill present new approaches to HIV vaccine development, improved diagnostic training, and a method for identifying high-HIV transmission areas. They also reveal the role of Epstein-Barr virus in mouth disorders associated with AIDS.
Over 5,000 experts worldwide support the Durban Declaration, stating that HIV is the cause of AIDS and urging governments to focus on prevention efforts. The declaration aims to eliminate misinformation and mobilize the world to combat the devastating consequences of AIDS.
The National Institute of Allergy and Infectious Diseases has launched four public-private partnerships to accelerate the development of promising HIV/AIDS vaccines. The partnerships aim to tap into the skills of both private industry and academic research centers, with a focus on developing vaccines for use around the world.
The Special Issue of Science documents the devastating impact of AIDS in sub-Saharan Africa, with 24.5 million HIV-infected people facing inaccessible treatments and preventive tactics. The article highlights the need for increased funding, estimated to be between $1.6 billion and $2.6 billion annually.
Scientists have created a novel dinucleotide molecule that appears to outlast existing treatments in cells. The integrase inhibitor has the potential to prevent HIV infection by blocking its ability to replicate in non-infected human cells.
AAAS and UCSF launch a premier online AIDS prevention information forum, linking peer-reviewed papers, daily features, and resources for scientists. The site aims to accelerate HIV vaccine development by facilitating global collaboration and information exchange.
Research reveals that individuals coping with HIV/AIDS exhibit diverse information-seeking behaviors, from avoiding information to seeking out multiple sources. Understanding these complexities is crucial in developing effective treatment programs, as uncertainty can be a natural part of life for some individuals.
Researchers link HIV-protease inhibitors to increased diabetes risk due to impaired glucose storage, prompting reevaluation of screening methods and development of new treatments. Up to 83% of patients on the drugs develop excess belly fat and type 2 diabetes.
A study published in AIDS found an association between osteopenia and protease inhibitors, a class of medications used to treat HIV/AIDS. Researchers discovered that patients taking these medications were more likely to develop low bone-mineral density, which can lead to fractures.
A recent study found that nearly 20% of smokers who attempted to quit in California used smoking cessation aids, including self-help materials, counseling, and nicotine replacement therapy. The use of these aids increased the odds of success in quitting, with 15% of those who sought assistance abstaining from cigarettes for 12 months.
People with AIDS-defining illnesses are at higher risk of developing memory loss and cognitive problems, including dementia. This poses a challenge for treatment adherence and overall public health.
A study by Duke University psychologists found that specific drugs for treating AIDS, heart disease, and depression have foul or bitter tastes that can stop patients from taking their medication. This phenomenon affects not only nutrition but also mood and well-being.
A study of 947 HIV-positive individuals found that hospital admission was linked to unemployment (82%) and poor health status (46%). The study also showed that having a physician experienced in HIV/AIDS management was beneficial for avoiding hospital admissions.
AIDS patients with limited emotional support are more likely to be nonadherent to their medication regimens. Confidence and social support significantly predict medication adherence, suggesting interventions should focus on enhancing these factors.
A preliminary study found that 38% of HIV-positive people in low-income hotels took over 90% of their medication, adhering well to combination anti-viral therapy. The researchers also discovered a close relationship between medication adherence and viral suppression, with levels of HIV doubling for every 10% of missed pills.
Researchers have identified a crucial molecule, DC-SIGN, that enables the AIDS virus to hijack dendritic cells, transporting it to immune system tissues where it infects T-lymphocytes. This breakthrough offers new avenues for developing treatments and potentially vaccines to prevent HIV infection.
The program will develop a curriculum for Community Health and Social Welfare Development Motivators to provide basic nursing tasks and support behavioral change in families and communities. The initiative aims to reduce stigma associated with HIV/AIDS and expand upon the work of various public and private organizations.
The new facility will enable researchers to conduct major studies on HIV-1C, a subtype responsible for more than half of the world's infections. The lab aims to identify prevention and treatment strategies to combat the spread of this devastating virus in southern Africa.
Case Western Reserve University has received a five-year, $10 million grant from the NIH to continue AIDS research that began 13 years ago. The grant enables area residents to participate in studies offering free HIV testing and newly developed drugs for treatment.
Researchers successfully demonstrated the effectiveness of a new oral form of ganciclovir to treat CMV retinitis, a blinding disorder that affects AIDS patients. The experimental valganciclovir offers a simpler treatment option with fewer pills needed per day.
AIDS patients with CMV in their blood are at increased risk of death, a new study suggests. The study found that 90% of UNC's AIDS patients have CMV exposure, and those with detectable virus levels had an 11-fold increased risk of death.
Research finds that combining AIDS drugs with cesarean delivery can reduce the risk of transmitting HIV to babies. The study, conducted in North Carolina from 1998 to 1999, showed a significant decrease in HIV transmission rates after these interventions were implemented.
The University of California, San Francisco is set to conduct a pioneering study on liver and kidney transplantation in HIV-infected patients. The research aims to determine the safety and efficacy of these procedures in individuals with end-stage liver and kidney disease, which are often fatal due to co-infection with hepatitis C virus.
A new model predicts that expanding potent HIV therapies will limit infections and AIDS deaths, even with increased risk behavior and drug resistance. The model shows that treating more HIV-infected men will reduce infection rates and deaths below what they would be without treatment.
Physicians at UNC-CH and Duke will receive funding to support care for people living with AIDS across North Carolina and clinical trials promising further medical progress. The renewed national Adult AIDS Clinical Trials Group (AACTG) funding reflects the quality of AIDS research and treatment in North Carolina.
Researchers found three distinct shedding patterns in HIV-positive men, related to viral sources and genetic strains. This discovery shifts the focus of AIDS vaccine research from blood-borne viruses to multiple strains in semen.
A new study published in the International Quarterly of Community Health Education found that campaigns to prevent high rates of HIV infections and AIDS along the Trans-Africa Highway are not working due to a lack of practical help like condoms. The research, conducted by a team from the University of Georgia and other institutions, fo...
The Adult AIDS Clinical Trials Group will receive $80 million in funding to continue studying antiviral interventions, immune system restoration, and opportunistic disease prevention. The network aims to improve patients' abilities to tolerate therapies and develop new strategies for treating HIV-related complications.
The U.S. is missing effective nationwide programs against HIV/AIDS, with the U.S. lagging behind countries like Switzerland and Thailand in implementing nationwide programs. Experts call for a national system of sexually transmitted disease protection to address this public health threat.
Researchers found a consistent pattern of viral evolution in individuals who later progressed to full-blown AIDS, allowing for preclinical stage recognition. This prediction may help target therapies to prevent or slow disease progression.
A new UCSF study reveals that gay men are more likely to smoke than the general male population, with 48% of participants in the research survey smoking compared to 27% of U.S. men. The study also found correlations between smoking and HIV status, heavy drinking, and frequenting gay bars.
The UCSF AIDS Research Institute is hosting a symposium to discuss strategies for preventing the second HIV epidemic. Experts will cover topics such as vaccine development, drug resistance, and post-exposure prevention.
A large-scale study found no clear evidence that name-based HIV reporting improves public health outcomes or increases timely medical care. Despite controversy, advocates argue the system helps notify partners and access healthcare, while opponents fear it deters testing.
Dr. Bruce D. Walker delivers a lecture on immune-mediated control of HIV infection, highlighting the Wistar/Philadelphia FIGHT Collaborative Project. The project combines basic immunotherapy with community-based research involving over 4,000 individuals living with HIV/AIDS.
World leaders discuss economic, ethical and human rights issues underlying healthcare resource allocation for HIV/AIDS. The meeting highlights the need for better balance of resources between prevention and treatment, as well as access to essential drugs and treatments.
Leaders from around the world will present and debate on various issues including trade reform, intellectual property rights and access to care and health services. The conference aims to explore practical solutions to bridge the gap between those who have access to healthcare and those who do not.
Research reveals striking increase in CD8 memory cells among HIV-positive teens, highlighting differences between male and female populations. The study provides a foundation for understanding adolescent immunity during HIV infection.
A recent study found that only 11% of young adults use condoms solely for AIDS prevention, while 41% use them exclusively for pregnancy prevention. The majority (48%) use condoms for both purposes, indicating a pragmatic approach to risk reduction.
A study by Rockefeller and Aaron Diamond researchers found that about one in six patients with the AIDS virus carried a strain resistant to at least one drug. The researchers recommend exploring the prevalence of this resistance and considering therapy structured around HIV-resistance testing to improve treatment effectiveness.
Researchers at the University of North Carolina will use a novel vaccine method to develop a safe and effective HIV vaccine. Early tests on monkeys show promise, with vaccinated animals showing significant cellular and humoral immunity and reduced virus load.
Research finds that revival in AIDS patients brings new uncertainties, affecting feelings of hope and future orientation, social roles and identities, interpersonal relationships, and changes in quality of life.
A nationwide study is being launched in six US cities to determine the most effective HIV prevention counseling program. The study, called EXPLORE, will compare two behavior interventions: standard risk reduction counseling and a client-centered approach that focuses on personal decision-making.
A new study suggests that hope plays a vital role in maintaining the health of HIV-positive men who have lost a loved one to AIDS. The researchers found that optimistic expectations and feelings of control over the disease are associated with a slower rate of progression of HIV-related illness.
Researchers found that CMV infection accelerates the progression of HIV in infants, leading to motor problems, stunted brain growth, pneumonia, and other symptoms of AIDS. The study sheds light on how viruses interact to cause disease and may lead to further understanding of why some individuals have a faster progression of HIV.
The University of California, San Francisco's HIV/AIDS website, HIV InSite, was recognized as one of the most comprehensive AIDS-related information resources in the world. The site, established two years ago, has garnered over 14 million hits from an international audience and is noted for its unbiased coverage of HIV/AIDS topics.
Researchers at UNC Health Care found that men with high stress levels and weak social support developed AIDS faster. The study of 82 HIV-infected gay men showed that cumulative stressful events doubled the risk of progressing to AIDS.